Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA)

Niven Mehra(Royal Marsden NHS Foundation Trust), Johann S. de Bono(Royal Marsden NHS Foundation Trust), Jane Goodall, Karim Fizazi(Université de Lille), Mario A. Eisenberger(Johns Hopkins University), Wei Yuan(Shanghai Public Health Clinical Center), Gunther Boysen, Mustapha Chadjaa(Sanofi (France)), David Dolling(Institute of Cancer Research), Rossitza Christova(Institute of Cancer Research), Stéphane Oudard(Assistance Publique – Hôpitaux de Paris), Emma Hall(Institute of Cancer Research), Penny Flohr(Royal Marsden NHS Foundation Trust), Oliver Sartor(Mayo Clinic), Sandrine Macé(Sanofi (France)), Suzanne Carreira(Institute of Cancer Research), Lorna Pope(Institute of Cancer Research), Semini Sumanasuriya(Institute of Cancer Research), Diletta Bianchini(Royal Marsden NHS Foundation Trust), George Seed(Institute of Cancer Research)

European Urology

February 28, 2018

Cited by 110

|Cell|2015|3.6k

|New England Journal of Medicine|2013|3.3k

|New England Journal of Medicine|2014|3k

|New England Journal of Medicine|2015|2.8k

|New England Journal of Medicine|2012|2.8k

Related Papers